Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 2.44%. However, over the past six months, we’ve seen a stronger performance of -10.69%. The price of SWTX leaped by -11.10% over the last 30 days. And in the last five days, it has fallen by -3.09%.
SpringWorks Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $53.92 on 03/08/24 and a low of $28.21 for the same time frame on 10/24/24.
52-week price history of SWTX Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. SpringWorks Therapeutics Inc’s current trading price is -31.36% away from its 52-week high, while its distance from the 52-week low is 31.19%. The stock’s price range during this time has been between $28.21 and $53.92. The trading volume for the Healthcare sector company’s shares reached about 3.63 million for the day, which was higher than the average daily volume of 1.21 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
SpringWorks Therapeutics Inc (SWTX) has experienced a quarterly rise of 21.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.75B and boasts a workforce of 305 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 35.99, with a change in price of +0.05. Similarly, SpringWorks Therapeutics Inc recorded 1,127,690 in trading volume during the last 100 days, posting a change of +0.14%.
SWTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SWTX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
SWTX Stock Stochastic Average
Today, SpringWorks Therapeutics Inc’s raw stochastic average for the past 50 days stands at 46.40%, indicating a rise from the raw stochastic average of the last 20 days, which was 23.51%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 51.45% and 56.53% respectively.
